COX-2 expression in dysplasia of the head and neck: Correlation with eIF4E

Cancer

Volumn 92, Issue 7, 2001, Pages 1888-1895

  Nathan, Cherie Ann O ^a,b   Leskov, Igor L ^a   Lin, Meihong ^a   Abreo, Fleurette W ^a   Shi, Runhua ^a   Hartman, Golda H ^a   Glass, Jonathan ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Biomarker; Cell lines; Chemoprevention; COX 2 inhibitors; Protooncogene; Squamous cell cancer

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; PROTEIN EIF4E; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; PRECANCEROUS CONDITIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RESPIRATORY MUCOSA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035476842     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011001)92:7<1888::AID-CNCR1706>3.0.CO;2-Z     Document Type: Article

References (46)

1. Head and neck cancer
2. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease
3. Field cancerization in oral stratified squamous epithelium: Clinical implications of multicentric origin
4. Upper aerodigestive tract carcinogenesis and chemoprevention
5. Prostaglandin-like material extracted from squamous carcinomas of the head and neck
6. Prostaglandins in squamous cell carcinoma of the head and neck: A preliminary study
7. Oral mucosal tumor inhibition by ibuprofen
8. Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin
9. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester
10. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
11. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor
12. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
13. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
14. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
15. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
16. Aberrations of growth and differentiation pathways during neoplastic transformation of human epithelial cells
17. The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas
18. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer
19. Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis
20. Analysis of surgical margins with the molecular marker eIF4E: A prognostic factor in patients with head and neck cancer
21. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: Prognostic implications
22. Expression of eIF4E during head and neck tumorigenesis: Possible role in angiogenesis
23. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas
24. Dysplasia lesions of the cervix
25. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers
26. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
27. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
28. Expression of cyclooxygenase-2 in human lung carcinoma
29. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
30. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
31. Cyclooxygenase-2 expression in human esophageal carcinoma
32. Aspirin and the potential role of prostaglandins in colon cancer
33. Cyclooxygenase gene expression in inflammation and angiogenesis
34. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
35. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: A general role for inflammation?
36. Aspirin, NSAIDs, and digestive tract cancers
37. Aspirin use and lung, colon, and breast cancer incidence in a prospective study
38. Nonsteroidal antiinflammatory drugs and breast cancer
39. 13-Cis-retinoic acid in the treatment of oral leukoplakia
40. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis
41. Retinoic acid is a negative regulator of AP-1-responsive genes
42. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2
43. Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer
44. Biomarkers as intermediate end points in chemoprevention trials
45. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes
46. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade